The FDA approved Allergan's Vraylar, or cariprazine, for use as a maintenance treatment for adult patients with schizophrenia and as an acute treatment of manic or mixed episodes of bipolar I disorder.
FDA approves Allergan's schizophrenia, bipolar I disorder drug
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.